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Introduction
Several  l ines of  evidence now attest  that  regular 
performance of aerobic physical exercise is pivotal 
for preserving or improving health and fitness, and shall 
hence be part of public health policies. This conclusion is 
actually supported by a kaleidoscope of metabolic changes 
that physical activity induces, and which translate into 
a consistently lower risk of developing cardiovascular, 
metabolic, musculoskeletal and even malignant disorders (1). 
Although the vast majority of favorable cardiovascular 
changes catalyzed by endurance running emerge as long-
term (chronic) effects on hemostasis (2) and on the lipid 
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profile (3,4), the acute impact of endurance exercise on 
plasma lipids remains controversial in the current scientific 
literature. Many previous endurance trials have frequently 
reported inconsistent variations of pro-atherogenic 
[i.e., low-density lipoprotein-cholesterol (LDL-C) and 
triglycerides] or anti-atherogenic [high-density lipoprotein-
cholesterol (HDL-C)] lipoprotein fractions, with ample 
inter-study variations (5-7). It is then noteworthy that most 
currently available studied were based on long-distance 
running (i.e., marathon or ultra-marathon), whilst data 
on acute effect of medium-distant running (i.e., between 
10–21 km), which is a more common recreational distance 
typically run by a larger number of recreational athletes, 
are completely lacking to the best of our knowledge. 
This seems a notable drawback, since lipid metabolism 
is directly dependent on running distance, with most 
changes becoming evident when covering running distances 
comprised between 10–21 km (8). Even less defined is the 
acute impact of endurance running on the lipid profile 
of diabetic patients, since information on this condition 
is completely lacking compared to euglycemic subjects. 
Therefore, this study was aimed to investigate the acute 
changes of plasma lipids after middle-distance running, and 
compare these variations between euglycemic and diabetic 
subjects.
Methods
Study design
The present research was part of an event called “Run 
For Science”, which is annually held under the auspices 
of University of Verona (Verona, Italy). Eleven male 
euglycemic amateur runners (mean age 41±6 years) and 9 
male diabetic amateur runners (4 with type 1 and 5 with 
type 2 diabetes; mean age 55±14 years) voluntarily engaged 
in a 21.1-km (i.e., half-marathon) running trial. The run 
started at around 7:30 AM on a mostly flat circuit (maximal 
slope, 1.8%), as thoughtfully described elsewhere (9). All 
subjects belonged to an amateur running team, and were 
regularly engaged in recreational running (at least 2 times 
a week). All subjects abstained from eating solid foods and 
strenuous physical activity for not less than 8 and 48 hours 
before the start of the trial, respectively. All diabetics were 
asked to continue their regular therapy with insulin and/or 
oral diabetes type 2 drugs throughout the period before the 
run. Athletes were only allowed to drink water (at libitum) 
throughout the running trial. Blood was drowned into 
evacuated blood collection tubes containing lithium-heparin 
as additive (Vacutest Kima s.r.l., Padova, Italy), before the 
start of the run and immediately after all subjects completed 
the trial. The blood samples were then conveyed to the 
service of Laboratory Medicine of the University Hospital 
of Verona (Verona, Italy).
Analysis of plasma lipids 
All blood samples were immediately centrifuged at 
1,300×g for 15 min at room temperature immediately 
after arrival in the laboratory. Lithium-heparin plasma 
was separated from the blood cell layer underneath and 
immediately analyzed. All measurements were performed 
in a single batch, with duplicate measures (final results 
were expressed as mean of the two measurements). Total 
cholesterol was measured with an enzymatic colorimetric 
assay (cholesterol oxidase reaction), HDL-C was assayed 
with a homogeneous enzymatic colorimetric assay 
(preliminary reaction with polyanions and detergent, 
fol lowed by cholesterol  oxidase reaction),  whilst 
triglycerides were measured with an enzymatic colorimetric 
assay (glycerophosphate oxidase reaction). The plasma 
concentration of LDL-C was finally calculated according 
to the validated formula of Friedewald et al. (10). Post-
run values were always corrected for the plasma volume 
change (PVC), according to the formula of Dill and 
Costill (11). All measurements were performed using the 
same Roche Cobas 6000 analyzer (Roche Diagnostics, 
Basel, Switzerland), during an identical analytical session. 
The within-run imprecision of all these assays is <1%, as 
quoted by the manufacturer.
Statistical analysis
Final results were normally distributed (according to 
Kolmogorov-Smirnov test), and were hence reported as 
mean and standard deviation (SD). The significance of 
differences was evaluated with paired or unpaired Student’s 
t-test, when appropriate. The level of statistical significance 
was set at P<0.05, and the statistical analysis was performed 
with Analyse-it (Analyse-it Software Ltd., Leeds, UK). All 
athletes signed a written informed consent for participating 
to this trial. The study was approved by the local ethical 
committee (Department of Neurosciences, Biomedicine and 
Movement Sciences, University of Verona, Verona, Italy; 
protocol number 165038) and performed in accordance 
with the Helsinki Declaration of 1975. 
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Results
Although diabetic subjects were on average 14 years older 
than euglycemic runners, the baseline values of all plasma 
lipids were found to be non-significantly different between 
diabetic and euglycemic subjects, as shown in Table 1. All 
athletes successfully completed the 21.1-km running trial, 
with running pace comprised between 9.6–12.8 km/h. The 
running pace did not significantly differ between diabetics 
and euglycemic subjects (P=0.131). The acute effect of the 
run on plasma volume and blood lipids is shown in Table 2. 
The plasma volume significantly increased by approximately 
6.9% (P=0.032) in euglycemic subjects, whilst it remained 
virtually unchanged in diabetics (−2.1%; P=0.466). In both 
categories of subjects the values of LDL-C was found to be 
significantly decreased after the run, while those of HDL-C 
and triglycerides were significantly increased (Table 2). 
Total cholesterol remained unchanged after the run in both 
categories of subjects. Notably, no significant difference 
was noted between diabetic and euglycemic subjects in the 
percent post-run variation of all lipoprotein fractions after 
the running trial (Figure 1).
Discussion
Although it is now undeniable that performing regular 
physical exercise is associated with many positive changes 
of lipid profile on the long-term (12), there is less 
convincing information on acute changes of plasma lipids 
after endurance running and, especially, no data has been 
published on the effect of middle-distance running (i.e., 
between 10–21 km) on the lipid profile in both euglycemic 
and diabetic subjects.
Some innovative results have emerged from this study, 
which may have some interesting and practical clinical 
implications. We first showed that middle-distance running 
induces some acute favorable changes in the lipoprotein 
profile. Namely, the pro-atherogenic LDL-C fraction was 
found to be significantly decreased by approximately 6%, 
whilst the anti-atherogenic HDL-C fraction displayed an 
opposite trend, with a 6–9% acute increase of its values 
(Table 2). Overall, this can be classified as a beneficial shift 
of lipid profile towards a more favorable condition, thus 
providing additional evidence to that already published in 
marathon and ultra-marathon runners. Kuusi et al studied 
Table 1 Lipoprotein fractions at baseline in euglycemic and diabetic subjects
Parameter Euglycemic subjects Diabetic subjects P
Number 11 9
Age (years) 41±6 55±14 0.012
Total cholesterol (mmol/L) 4.82±0.82 4.19±0.60 0.072
LDL-C (mmol/L) 2.78±0.75 2.31±0.52 0.135
HDL-C (mmol/L) 1.65±0.24 1.47±0.44 0.257
Triglycerides (mmol/L) 0.85±0.30 1.04±0.50 0.311
LDL-C, low-density lipoprotein cholesterol; HDL-C, high-density lipoprotein cholesterol. 
Table 2 Percent variation of lipoprotein fractions after a 21.1-km running trial
Parameter
Euglycemic subjects Diabetic subjects
Value P vs. baseline Value P vs. baseline
Plasma volume 6.9±8.4% 0.032 −2.1±6.6% 0.466
Total cholesterol 1±4% 0.335 2±8% 0.455
LDL-C −6±5% 0.001 −6±7% 0.039
HDL-C 6±4% 0.001 9±7% 0.004
Triglycerides 36±49% 0.032 30±28% 0.010
All lipid values have been corrected for the plasma volume change. LDL-C, low-density lipoprotein cholesterol; HDL-C, high-density 
lipoprotein cholesterol. 
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20 healthy amateur runners who participated to the First 
North Karelian Heart Marathon, and showed that the 
HDL-C fraction significantly increased by approximately 
7% at the end of the run (5). Unlike our findings, however, 
they failed to find any significant variation of the LDL-C 
fraction, which remained virtually unchanged after the 
end of the marathon. Notably, no significant variations 
were also observed for total cholesterol and triglycerides. 
Similar results were reported by Liu et al. (6), who also 
studied 11 well-trained male runners participating to the 
Helsinki City Marathon, and failed to find any significant 
variation in the lipid profile after completing the running 
distance except for HDL-C fraction, which increased by 
approximately 3%. In an ensuing study, Emed et al. studied 
16 male athletes who took part to an ultramarathon run 
(mean distance covered, 134 km) (7), and found that neither 
total cholesterol or LDL-C, HDL-C and triglyceride 
values significantly changed after this strenuous trial, thus 
concluding that the lipid profile was unaltered by strenuous, 
long-distance running. 
A second remarkable aspect emerged from our study. 
The acute beneficial changes of physical exercise on the 
lipid profile were found to be virtually identical between 
euglycemic and diabetic subjects, thus providing further 
support and reinforcing the recommendations of fostering 
physical activity programs in prevention and management 
of diabetes (13). Interestingly, our data complement those 
already published on the beneficial influence of a single 
exercise session in diabetics for increasing bioavailability of 
nitric oxide, eliciting reduction of blood pressure, enhancing 
carbohydrate oxidation and fat oxidation, thus ultimately 
ameliorating insulin sensitivity and glucose tolerance (14). All 
these acute changes, combined with evidence that middle-
distance running would actually contribute to acutely 
ameliorate the lipid profile, persuade us to suggest that this 
form of exercise may be highly indicated in diabetics.
Conclusions
In conclusion, the results of our original study convincingly 
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Figure 1 Percent variation of lipoprotein fractions after a 21.1-km running trial. All lipid values have been corrected for the plasma volume 
change. LDL-C, low-density lipoprotein cholesterol; HDL-C, high-density lipoprotein cholesterol. 
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show for the first time that middle-distance running 
elicits favorable acute changes of the lipid profile, both in 
euglycemic and diabetic subjects. Therefore, this form of 
common and sustainable endurance exercise shall be further 
fostered for purposes of public health promotion and 
improvement.
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